Stocks and Investing Stocks and Investing
Tue, November 2, 2021
Mon, November 1, 2021

Christopher Raymond Maintained (ABBV) at Buy with Increased Target to $129 on, Nov 1st, 2021


Published on 2024-10-27 18:26:43 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $124 to $129 on, Nov 1st, 2021.

Christopher has made no other calls on ABBV in the last 4 months.



There are 3 other peers that have a rating on ABBV. Out of the 3 peers that are also analyzing ABBV, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $119 on, Monday, August 2nd, 2021


These are the ratings of the 2 analyists that currently disagree with Christopher


  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $130 on, Monday, August 23rd, 2021
  • Robyn Karnauskas of "Truist Securities" Initiated at Strong Buy and Held Target at $118 on, Monday, July 26th, 2021
Contributing Sources